Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Tara Comonte
AddedMar 31, 2024
UpdatedMay 31, 2026
Tara Comonte

Tara Comonte

Board Member, WW International

LinkedIn

Tara Comonte's Career

WW International
WW International

New York City, NY, US

Board Member· Board
Strava
Strava

San Francisco, CA, US

Board Member· Board
Tmrw Life Sciences
Tmrw Life Sciences

New York City, NY, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Tara Comonte's Career

WW International
WW International
Public7.1k1963New York City, NY, US
Board Member· Board

Recent news

Bret Taylor’s customer service AI startup just raised $175MTechCrunch · 2024

Leadership at WW International

Thilo SemmelbauerThilo SemmelbauerBoard Member
Sima SistaniSima SistaniBoard Member
Oprah WinfreyOprah WinfreyBoard Member
Julie RiceJulie RiceBoard Member
Raymond DebbaneRaymond DebbaneBoard Member
Julie BornsteinJulie BornsteinBoard Member
Strava
Strava
Series F$151.8M4302009San Francisco, CA, US
Board Member· Board

Recent news

The company behind ClassPass and Mindbody just got a lot bigger with a $7.5B mergerTechCrunch · 2026
Startups Weekly: Cutting through Google I/O noiseTechCrunch · 2025
Daily Crunch: Twitter CEO admits he purchased platform for $44B because ‘I kind of had to’TechCrunch · 2023

Leadership at Strava

Mark GaineyMark GaineyBoard Member
Kevin WeilKevin WeilBoard Member
Lane KasselmanLane KasselmanBoard Member
Jameson J. McJunkinJameson J. McJunkinBoard Member
Ariel PolerAriel PolerBoard Member
Sarah Robb O'HaganSarah Robb O'HaganBoard Member
Tmrw Life Sciences
Tmrw Life Sciences
Angel$153.5M1072018New York City, NY, US
Board Member· Board

Leadership at Tmrw Life Sciences

Jeffrey PortJeffrey PortCo-Founder
Joshua AbramJoshua AbramBoard Member
Alan MurrayAlan MurrayBoard Member
Louis VillalbaLouis VillalbaCEO
Emily Drabant ConleyEmily Drabant ConleyBoard Member

Similar to Tmrw Life Sciences

Conceivable Life SciencesConceivable Life SciencesNew York City, NY, USFertility Treatmentsest. 2022Conceivable Life SciencesNew York City, NY, US · est. 2022

Conceivable Life Sciences: Automating IVF labs for accessible fertility treatments.

Seed · $20M12
Overture LifeOverture LifeNew York City, NY, USFertility Treatments, IVFest. 2017Overture LifeNew York City, NY, US · est. 2017

Overture Life, a biotech firm, innovates IVF through automation and non-invasive selection, making fertility treatments affordable and reliable.

Series B · $45M42
Darwin LifeDarwin LifeNew York City, NY, USIVF Technologyest. 2015Darwin LifeNew York City, NY, US · est. 2015

Darwin Life, a biotech firm, innovates in vitro fertilization tech to reverse aging effects on oocytes and prevent diseases.

Pre-Seed · $1M6
AlifeAlifeSan Francisco, CA, USAI Softwareest. 2020AlifeSan Francisco, CA, US · est. 2020

Alife Health: Pioneering AI tools for modern IVF systems, partnering with top institutions for healthier children.

Series A · $31.5M80

Tara Comonte's Similar Executives & Operators

Jay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoYun SeokYun SeokBoard Member · Kakao

People Similar to Tara Comonte

Christopher SobeckiChristopher SobeckiBoard Member · Lexicon PharmaceuticalsSima D SistaniSima D SistaniCEO · WW InternationalCraig SmithCraig SmithBoard Member · AlgenolAsh TahaAsh TahaCEO · SpineloopBill TaaffeBill TaaffeBoard Member · Strategikon Pharma